Logo image of ACT

ENACT HOLDINGS INC (ACT) Stock Fundamental Analysis

USA - NASDAQ:ACT - US29249E1091 - Common Stock

39.1 USD
+0.41 (+1.06%)
Last: 9/26/2025, 8:00:00 PM
39.1 USD
0 (0%)
After Hours: 9/26/2025, 8:00:00 PM
Fundamental Rating

4

Taking everything into account, ACT scores 4 out of 10 in our fundamental rating. ACT was compared to 100 industry peers in the Financial Services industry. ACT has an average financial health and profitability rating. ACT has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year ACT was profitable.
ACT had a positive operating cash flow in the past year.
ACT had positive earnings in each of the past 5 years.
Each year in the past 5 years ACT had a positive operating cash flow.
ACT Yearly Net Income VS EBIT VS OCF VS FCFACT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

1.2 Ratios

With an excellent Return On Assets value of 9.99%, ACT belongs to the best of the industry, outperforming 90.10% of the companies in the same industry.
ACT has a Return On Equity of 12.96%. This is in the better half of the industry: ACT outperforms 67.33% of its industry peers.
Industry RankSector Rank
ROA 9.99%
ROE 12.96%
ROIC N/A
ROA(3y)11.21%
ROA(5y)9.9%
ROE(3y)15.1%
ROE(5y)13.63%
ROIC(3y)N/A
ROIC(5y)N/A
ACT Yearly ROA, ROE, ROICACT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 55.35%, ACT belongs to the top of the industry, outperforming 93.07% of the companies in the same industry.
ACT's Profit Margin has declined in the last couple of years.
The Operating Margin of ACT (74.60%) is better than 95.05% of its industry peers.
In the last couple of years the Operating Margin of ACT has remained more or less at the same level.
Industry RankSector Rank
OM 74.6%
PM (TTM) 55.35%
GM N/A
OM growth 3Y5.43%
OM growth 5Y1.29%
PM growth 3Y5.4%
PM growth 5Y-3.72%
GM growth 3YN/A
GM growth 5YN/A
ACT Yearly Profit, Operating, Gross MarginsACT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

4

2. Health

2.1 Basic Checks

The number of shares outstanding for ACT has been reduced compared to 1 year ago.
ACT has less shares outstanding than it did 5 years ago.
The debt/assets ratio for ACT has been reduced compared to a year ago.
ACT Yearly Shares OutstandingACT Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
ACT Yearly Total Debt VS Total AssetsACT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

The Debt to FCF ratio of ACT is 1.06, which is an excellent value as it means it would take ACT, only 1.06 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of ACT (1.06) is better than 85.15% of its industry peers.
A Debt/Equity ratio of 0.14 indicates that ACT is not too dependend on debt financing.
ACT has a Debt to Equity ratio of 0.14. This is in the better half of the industry: ACT outperforms 77.23% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 1.06
Altman-Z N/A
ROIC/WACCN/A
WACCN/A
ACT Yearly LT Debt VS Equity VS FCFACT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
ACT Yearly Current Assets VS Current LiabilitesACT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2021 2022 2023 2024 5M 10M 15M 20M

4

3. Growth

3.1 Past

ACT shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.41%.
The Earnings Per Share has been growing slightly by 0.98% on average over the past years.
Looking at the last year, ACT shows a small growth in Revenue. The Revenue has grown by 3.16% in the last year.
The Revenue has been growing slightly by 4.19% on average over the past years.
EPS 1Y (TTM)4.41%
EPS 3Y9.13%
EPS 5Y0.98%
EPS Q2Q%-9.45%
Revenue 1Y (TTM)3.16%
Revenue growth 3Y2.44%
Revenue growth 5Y4.19%
Sales Q2Q%2.03%

3.2 Future

The Earnings Per Share is expected to grow by 3.70% on average over the next years.
The Revenue is expected to grow by 2.96% on average over the next years.
EPS Next Y-1.93%
EPS Next 2Y1.02%
EPS Next 3Y3.7%
EPS Next 5YN/A
Revenue Next Year2.04%
Revenue Next 2Y2.78%
Revenue Next 3Y2.96%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ACT Yearly Revenue VS EstimatesACT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
ACT Yearly EPS VS EstimatesACT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 8.69 indicates a reasonable valuation of ACT.
79.21% of the companies in the same industry are more expensive than ACT, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 27.54, ACT is valued rather cheaply.
A Price/Forward Earnings ratio of 8.40 indicates a reasonable valuation of ACT.
70.30% of the companies in the same industry are more expensive than ACT, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of ACT to the average of the S&P500 Index (23.05), we can say ACT is valued rather cheaply.
Industry RankSector Rank
PE 8.69
Fwd PE 8.4
ACT Price Earnings VS Forward Price EarningsACT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

81.19% of the companies in the same industry are more expensive than ACT, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 8.23
EV/EBITDA N/A
ACT Per share dataACT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)8.89
EPS Next 2Y1.02%
EPS Next 3Y3.7%

4

5. Dividend

5.1 Amount

ACT has a Yearly Dividend Yield of 2.17%. Purely for dividend investing, there may be better candidates out there.
ACT's Dividend Yield is a higher than the industry average which is at 5.19.
Compared to an average S&P500 Dividend Yield of 2.41, ACT has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.17%

5.2 History

ACT has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
ACT Yearly Dividends per shareACT Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

ACT pays out 17.25% of its income as dividend. This is a sustainable payout ratio.
DP17.25%
EPS Next 2Y1.02%
EPS Next 3Y3.7%
ACT Yearly Income VS Free CF VS DividendACT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
ACT Dividend Payout.ACT Dividend Payout, showing the Payout Ratio.ACT Dividend Payout.PayoutRetained Earnings

ENACT HOLDINGS INC

NASDAQ:ACT (9/26/2025, 8:00:00 PM)

After market: 39.1 0 (0%)

39.1

+0.41 (+1.06%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)07-30 2025-07-30/amc
Earnings (Next)11-04 2025-11-04/amc
Inst Owners21.96%
Inst Owner Change6.11%
Ins Owners0.41%
Ins Owner Change-3.28%
Market Cap5.77B
Analysts76
Price Target40.8 (4.35%)
Short Float %10.74%
Short Ratio9.5
Dividend
Industry RankSector Rank
Dividend Yield 2.17%
Yearly Dividend0.72
Dividend Growth(5Y)N/A
DP17.25%
Div Incr Years0
Div Non Decr Years0
Ex-Date08-18 2025-08-18 (0.21)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.18%
Min EPS beat(2)1.16%
Max EPS beat(2)3.2%
EPS beat(4)4
Avg EPS beat(4)5.92%
Min EPS beat(4)1.16%
Max EPS beat(4)15.04%
EPS beat(8)8
Avg EPS beat(8)9.69%
EPS beat(12)12
Avg EPS beat(12)14.26%
EPS beat(16)16
Avg EPS beat(16)15.63%
Revenue beat(2)1
Avg Revenue beat(2)-0.68%
Min Revenue beat(2)-1.86%
Max Revenue beat(2)0.5%
Revenue beat(4)2
Avg Revenue beat(4)-1.14%
Min Revenue beat(4)-3.4%
Max Revenue beat(4)0.5%
Revenue beat(8)3
Avg Revenue beat(8)-0.9%
Revenue beat(12)4
Avg Revenue beat(12)-0.85%
Revenue beat(16)5
Avg Revenue beat(16)-1%
PT rev (1m)0%
PT rev (3m)1.27%
EPS NQ rev (1m)0.37%
EPS NQ rev (3m)0.53%
EPS NY rev (1m)1.55%
EPS NY rev (3m)1.7%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.56%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.4%
Valuation
Industry RankSector Rank
PE 8.69
Fwd PE 8.4
P/S 4.72
P/FCF 8.23
P/OCF 8.23
P/B 1.1
P/tB 1.1
EV/EBITDA N/A
EPS(TTM)4.5
EY11.51%
EPS(NY)4.65
Fwd EY11.9%
FCF(TTM)4.75
FCFY12.15%
OCF(TTM)4.75
OCFY12.15%
SpS8.29
BVpS35.41
TBVpS35.41
PEG (NY)N/A
PEG (5Y)8.89
Profitability
Industry RankSector Rank
ROA 9.99%
ROE 12.96%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 74.6%
PM (TTM) 55.35%
GM N/A
FCFM 57.28%
ROA(3y)11.21%
ROA(5y)9.9%
ROE(3y)15.1%
ROE(5y)13.63%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)15.25%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y5.43%
OM growth 5Y1.29%
PM growth 3Y5.4%
PM growth 5Y-3.72%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.18
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 1.06
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion N/A
Profit Quality 103.47%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)91.43%
Profit Quality(5y)113.82%
High Growth Momentum
Growth
EPS 1Y (TTM)4.41%
EPS 3Y9.13%
EPS 5Y0.98%
EPS Q2Q%-9.45%
EPS Next Y-1.93%
EPS Next 2Y1.02%
EPS Next 3Y3.7%
EPS Next 5YN/A
Revenue 1Y (TTM)3.16%
Revenue growth 3Y2.44%
Revenue growth 5Y4.19%
Sales Q2Q%2.03%
Revenue Next Year2.04%
Revenue Next 2Y2.78%
Revenue Next 3Y2.96%
Revenue Next 5YN/A
EBIT growth 1Y-0.5%
EBIT growth 3Y8.01%
EBIT growth 5Y5.53%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y28.3%
FCF growth 3Y6.25%
FCF growth 5Y6.54%
OCF growth 1Y28.3%
OCF growth 3Y6.25%
OCF growth 5Y6.54%